Literature DB >> 20643588

Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanup.

Magdalena Korecka1, Christopher M Clark, Virginia M-Y Lee, John Q Trojanowski, Leslie M Shaw.   

Abstract

Quantitation of isoprostanes such as 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha)-VI in biological fluids has been proposed as a reliable test of oxidant stress and inflammation in a variety of disorders. This paper presents a liquid chromatography method with tandem mass spectrometry detection for the simultaneous analysis of these two isoprostanes in human CSF and brain tissue samples. An API 5000 triple quadrupole instrument (AB Sciex, Foster City, CA, USA) with an APCI ion source was used in this study. Aliquots of CSF samples (0.25mL) were treated with a methanol:zinc sulfate mixture followed by on-line cleanup on an extraction column (Validated-C(18)) with 0.1% formic acid. The brain tissue samples were homogenized and lipids were extracted using Folch solution. Solid-phase extraction columns (C(18)) were used for the purification of the brain isoprostane fraction. Chromatographic separation was achieved using an analytical column (Synergi C(18) HydroRP) with 0.1% formic acid in water and a mixture of methanol:acetonitrile under isocratic conditions. The mass spectrometer was operated in the MRM scan and negative ion mode. The quadrupoles were set to detect the molecular ions [M-H](-) and high mass fragments of isoprostanes: m/z 353-->193amu (8-iso-PGF(2alpha)) and m/z 353-->115amu (8,12-iso-iPF(2alpha)-VI) and their deuterated internal standards: m/z 357-->197amu (8-iso-PGF(2alpha)-d(4)) and m/z 364-->115amu (8,12-iso-iPF(2alpha)-VI-d(11)). The lower limit of quantification was 2.5pg/mL for 8-iso-PGF(2alpha) and 5.0pg/mL for 8,12-iso-PF(2alpha)-VI for the CSF method and 10.0pg/0.1g of tissue and 30.0pg/0.1g of tissue for 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha)-VI, respectively, for the brain tissue method. No ion suppression or enhancement of the detection of 8-isoPGF(2alpha), 8,12-isoPF(2alpha)-VI or both internal standards was found. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643588      PMCID: PMC2975066          DOI: 10.1016/j.jchromb.2010.06.029

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  31 in total

Review 1.  Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.

Authors:  Paul J Taylor
Journal:  Clin Biochem       Date:  2005-04       Impact factor: 3.281

2.  HPLC-atmospheric pressure chemical ionization MS/MS for quantification of 15-F2t-isoprostane in human urine and plasma.

Authors:  Manuel Haschke; Yan Ling Zhang; Christine Kahle; Jelena Klawitter; Magdalena Korecka; Leslie M Shaw; Uwe Christians
Journal:  Clin Chem       Date:  2007-01-26       Impact factor: 8.327

3.  Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations.

Authors:  B K Matuszewski; M L Constanzer; C M Chavez-Eng
Journal:  Anal Chem       Date:  1998-03-01       Impact factor: 6.986

Review 4.  F2-isoprostanes in Alzheimer and other neurodegenerative diseases.

Authors:  Thomas J Montine; Kathleen S Montine; Wendy McMahan; William R Markesbery; Joseph F Quinn; Jason D Morrow
Journal:  Antioxid Redox Signal       Date:  2005 Jan-Feb       Impact factor: 8.401

5.  IPF2alpha-I: an index of lipid peroxidation in humans.

Authors:  D Praticò; O P Barry; J A Lawson; M Adiyaman; S W Hwang; S P Khanapure; L Iuliano; J Rokach; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 6.  Isoprostanes: markers and mediators of oxidative stress.

Authors:  Paolo Montuschi; Peter J Barnes; L Jackson Roberts
Journal:  FASEB J       Date:  2004-12       Impact factor: 5.191

7.  Ion trap tandem mass spectrometric determination of F2-isoprostanes.

Authors:  Cinzia Signorini; Mario Comporti; Gianluca Giorgi
Journal:  J Mass Spectrom       Date:  2003-10       Impact factor: 1.982

8.  Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine.

Authors:  J A Lawson; H Li; J Rokach; M Adiyaman; S W Hwang; S P Khanapure; G A FitzGerald
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

9.  Validation of 8-isoprostane and prostaglandin E(2) measurements in exhaled breath condensate.

Authors:  P Montuschi; E Ragazzoni; S Valente; G Corbo; C Mondino; G Ciappi; G Ciabattoni
Journal:  Inflamm Res       Date:  2003-11-13       Impact factor: 4.575

10.  Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress.

Authors:  J D Morrow; L J Roberts
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

View more
  7 in total

Review 1.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  Analysis of F2-isoprostanes in plasma of pregnant women by HPLC-MS/MS using a column packed with core-shell particles.

Authors:  Jessica Larose; Pierre Julien; Jean-François Bilodeau
Journal:  J Lipid Res       Date:  2013-02-21       Impact factor: 5.922

3.  Influence of lifestyle modifications on age-related free radical injury to brain.

Authors:  Elaine R Peskind; Ge Li; Jane B Shofer; Steven P Millard; James B Leverenz; Chang-En Yu; Murray A Raskind; Joseph F Quinn; Douglas R Galasko; Thomas J Montine
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

4.  Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.

Authors:  Timothy C Durazzo; Magdalena Korecka; John Q Trojanowski; Michael W Weiner; Ruth O' Hara; John W Ashford; Leslie M Shaw
Journal:  J Alzheimers Dis       Date:  2016-07-25       Impact factor: 4.472

Review 5.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

Review 6.  Lipidomic analysis of cerebrospinal fluid by mass spectrometry-based methods.

Authors:  Benoit Colsch; Alexandre Seyer; Samia Boudah; Christophe Junot
Journal:  J Inherit Metab Dis       Date:  2014-12-09       Impact factor: 4.982

7.  History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner; Magdalena Korecka; John Q Trojanowski; Leslie M Shaw
Journal:  Drug Alcohol Depend       Date:  2014-07-03       Impact factor: 4.492

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.